200 related articles for article (PubMed ID: 36417134)
1. Adjuvant Therapy in Node-Positive Endometrial Cancer: A Focus on Chemotherapy.
Dexter J; Lips E; DiSilvestro P
Curr Oncol Rep; 2022 Dec; 24(12):1677-1683. PubMed ID: 36417134
[TBL] [Abstract][Full Text] [Related]
2. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy for advanced endometrial cancer.
Galaal K; Al Moundhri M; Bryant A; Lopes AD; Lawrie TA
Cochrane Database Syst Rev; 2014 May; 2014(5):CD010681. PubMed ID: 24832785
[TBL] [Abstract][Full Text] [Related]
4. What's new in systemic therapy for endometrial cancer.
Kieser K; Oza AM
Curr Opin Oncol; 2005 Sep; 17(5):500-4. PubMed ID: 16093803
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy.
van den Heerik ASVM; Horeweg N; de Boer SM; Bosse T; Creutzberg CL
Int J Gynecol Cancer; 2021 Apr; 31(4):594-604. PubMed ID: 33082238
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Therapy for High-risk Endometrial Carcinoma.
Perera J; Hoskin P
Clin Oncol (R Coll Radiol); 2021 Sep; 33(9):560-566. PubMed ID: 34112584
[TBL] [Abstract][Full Text] [Related]
7. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
[TBL] [Abstract][Full Text] [Related]
8. [Preliminary study of sequential multi-modality adjuvant chemotherapy and radiation for advanced endometrial cancer].
Zhang G; Suo HY; Shen XY; Zhao LJ; Wang ZQ; Kong WM; Li XP; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2019 Feb; 54(2):103-109. PubMed ID: 30803169
[No Abstract] [Full Text] [Related]
9. Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study.
Felix AS; Cohn DE; Brasky TM; Zaino R; Park K; Mutch DG; Creasman WT; Thaker PH; Walker JL; Moore RG; Lele SB; Guntupalli SR; Downs LS; Nagel CI; Boggess JF; Pearl ML; Ioffe OB; Randall ME; Brinton LA
Am J Obstet Gynecol; 2018 Nov; 219(5):459.e1-459.e11. PubMed ID: 30096321
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy in endometrial carcinoma: overview of randomised trials.
Hogberg T
Clin Oncol (R Coll Radiol); 2008 Aug; 20(6):463-9. PubMed ID: 18467080
[TBL] [Abstract][Full Text] [Related]
11. [The first Mexican consensus of endometrial cancer. Grupo de Investigación en Cáncer de Ovario y Tumores Ginecológicos de México].
Ruvalcaba-Limón E; Cantú-de-León D; León-Rodríguez E; Cortés-Esteban P; Serrano-Olvera A; Morales-Vásquez F; Sosa-Sánchez R; Poveda-Velasco A; Crismatt-Zapata A; Santillán-Gómez A; Aguilar-Jiménez C; Alanís-López P; Alfaro-Ramírez P; Alvarez-Avitia MA; Aranda-Flores CE; Arias-Ceballos JH; Arrieta-Rodríguez O; Barragán-Curiel E; Botello-Hernández D; Brom-Valladares R; Cabrera-Galeana PA; Cantón-Romero JC; Capdeville-García D; Cárdenas-Sánchez J; Castorena-Roji G; Cepeda-López FR; Cervantes-Sánchez G; Cetina-Pérez Lde C; Coronel-Martínez JA; Cortés-Cárdenas SA; Cruz-López JC; de la Garza-Salazar JG; Díaz-Romero C; Dueñas-González A; Valle-Solís AE; Escudero-de los Ríos P; Flores-Alvarez E; García-Matus R; Gerson-Cwilich R; González-Enciso A; González-de-León C; Guevara-Torres AG; Herbert-Núñez GS; Hernández-Hernández C; Hernández-Hernández DM; Isla-Ortiz D; Jesús-Sandoval R; Jiménez-Cervantes C; Kuri-Exsome R; López-Obispo JL; Maffuz-Aziz A; Martínez-Barrera LM; Medina-Castro JM; Montalvo-Esquivel G; Mora-Aguilar VH; Morales-Palomares MA; Morán-Mendoza A; Morgan-Villela G; Mota-García A; Muñoz-González DE; Murillo-Cruz DA; Novoa-Vargas A; Ochoa-Carrillo FJ; Oñate-Ocaña LF; Ortega-Rojo A; Palacios-Martínez AG; Palomeque-López A; Pérez-Montiel MD; Quijano-Castro F; Rivera-Rivera S; Rivera-Rubí LM; Robles-Flores JU; Rodríguez-Trejo A; Salas-Gonzáles E; Silva JA; Solorza-Luna G; Souto-del-Bosque R; Tirado-Gómez LL; Torrescano-González S; Torres-Lobatón A; Trejo-Durán E; Villavicencio-Valencia V; Gallardo-Rincón D;
Rev Invest Clin; 2010; 62(6):583, 585-605. PubMed ID: 21416918
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers as prognostic factors in endometrial cancer.
Dobrzycka B; Terlikowski SJ
Folia Histochem Cytobiol; 2010 Sep; 48(3):319-22. PubMed ID: 21071332
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemo-radiotherapy in the "sandwich" method for high risk endometrial cancer--a review of literature.
Bie Y; Zhang Z; Wang X
BMC Womens Health; 2015 Jun; 15():50. PubMed ID: 26104468
[TBL] [Abstract][Full Text] [Related]
14. Systemic therapy for the treatment of endometrial cancer.
Neri M; Peiretti M; Melis GB; Piras B; Vallerino V; Paoletti AM; Madeddu C; Scartozzi M; Mais V
Expert Opin Pharmacother; 2019 Nov; 20(16):2019-2032. PubMed ID: 31451034
[No Abstract] [Full Text] [Related]
15. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies.
Hogberg T; Signorelli M; de Oliveira CF; Fossati R; Lissoni AA; Sorbe B; Andersson H; Grenman S; Lundgren C; Rosenberg P; Boman K; Tholander B; Scambia G; Reed N; Cormio G; Tognon G; Clarke J; Sawicki T; Zola P; Kristensen G
Eur J Cancer; 2010 Sep; 46(13):2422-31. PubMed ID: 20619634
[TBL] [Abstract][Full Text] [Related]
16. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy for high-risk early-stage endometrial cancer.
Kodama J; Seki N; Hiramatsu Y
Curr Opin Obstet Gynecol; 2007 Feb; 19(1):42-7. PubMed ID: 17218851
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant treatment for stage IIIC endometrial cancer: options and controversies.
Shah PH; Kudrimoti M; Feddock J; Randall M
Gynecol Oncol; 2011 Sep; 122(3):675-83. PubMed ID: 21664661
[TBL] [Abstract][Full Text] [Related]
19. Evolution of adjuvant treatment in endometrial cancer-no evidence and new questions?
Marnitz S; Köhler C; Gharbi N; Kunze S; Jablonska K; Herter J
Strahlenther Onkol; 2018 Nov; 194(11):965-974. PubMed ID: 30112692
[TBL] [Abstract][Full Text] [Related]
20. Advances in the management of endometrial adenocarcinoma. A review.
Irvin WP; Rice LW; Berkowitz RS
J Reprod Med; 2002 Mar; 47(3):173-89; discussion 189-90. PubMed ID: 11933681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
